We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

179 hedge funds and large institutions have $2.35B invested in Nektar Therapeutics in 2015 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 70 increasing their positions, 50 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

52% more capital invested

Capital invested by funds: $1.55B → $2.35B (+$799M)

40% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 50

8% more funds holding

Funds holding: 166 → 179 (+13)

7% more call options, than puts

Call options by funds: $5.89M | Put options by funds: $5.51M

Holders
179
Holders Change
+13
Holders Change %
+7.83%
% of All Funds
4.7%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.1%
New
35
Increased
70
Reduced
50
Closed
20
Calls
$5.89M
Puts
$5.51M
Net Calls
+$384K
Net Calls Change
+$263K

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$21.4M
2
CCM
Camber Capital Management
Massachusetts
+$17.1M
3
Deutsche Bank
Deutsche Bank
Germany
+$10.4M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$8.11M
5
RHJA
Rice Hall James & Associates
California
+$5.18M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$40.2M
2
State Street
State Street
Massachusetts
-$19.1M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$14M
4
BJCM
Blue Jay Capital Management
California
-$12.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
126
Point72 Asset Management
Connecticut
$295K -$1.65M -8,000 -87%
TI
127
Trexquant Investment
Connecticut
$293K -$44.2K -215 -16%
PAM
128
Paradigm Asset Management
New York
$290K +$236K +1,147 New
QIM
129
Quantitative Investment Management
Virginia
$283K -$356K -1,733 -61%
LCM
130
Leisure Capital Management
California
$278K +$5.14K +25 +2%
MCI
131
McDonald Capital Investors
California
$270K -$13.4K -65 -6%
RG
132
Rathbones Group
United Kingdom
$235K – – –
SIM
133
Spark Investment Management
New York
$230K -$709K -3,447 -79%
FIM
134
Freedom Investment Management
Connecticut
$230K +$187K +911 New
KAM
135
Kazazian Asset Management
Florida
$224K -$371K -1,805 -67%
GVT
136
Genesee Valley Trust
New York
$218K -$411 -2 -0.2%
AB
137
Amalgamated Bank
New York
$213K -$16.9K -82 -9%
JG
138
Jefferies Group
New York
$211K -$152K -740 -47%
Two Sigma Advisers
139
Two Sigma Advisers
New York
$208K +$169K +822 New
Teacher Retirement System of Texas
140
Teacher Retirement System of Texas
Texas
$204K -$54.9K -267 -25%
Stifel Financial
141
Stifel Financial
Missouri
$201K +$164K +797 New
VKH
142
Virtu KCG Holdings
New York
$195K +$159K +773 New
AIM
143
Ada Investment Management
New York
$194K +$158K +769 New
Capital Fund Management (CFM)
144
Capital Fund Management (CFM)
France
$189K +$154K +747 New
CCMH
145
Cornerstone Capital Management Holdings
New York
$187K +$152K +740 New
AIP
146
Ameritas Investment Partners
Nebraska
$171K – – –
SCM
147
Shelton Capital Management
Colorado
$171K – – –
Canada Life
148
Canada Life
Manitoba, Canada
$166K – – –
CG
149
Cutler Group
California
$148K +$121K +586 New
FMT
150
First Mercantile Trust
Tennessee
$135K +$110K +534 New
4 5
6
7 8

NKTR Hedge Fund Activity: Q4 2015 in Review

179 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q4 2015, worth a combined $2.35B — up 52% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new NKTR positions and 20 closed out — a net gain of 15 holders — while 70 added to existing stakes and 50 trimmed.

The largest buyer was Bridger Management, opening a new position worth an estimated $21.4M. The largest seller was Millennium Management, cutting an estimated $40.2M.

  • 179 institutional investors held Nektar Therapeutics (NKTR) as of Q4 2015, up from 166 in Q3 2015.
  • Funds reported $2.35B of Nektar Therapeutics stock for Q4 2015, up 52% quarter-over-quarter.
  • 35 funds opened new Nektar Therapeutics positions in Q4 2015 and 20 closed out, a net change of +15 holders.
  • The largest Nektar Therapeutics buyer in Q4 2015 was Bridger Management, an estimated $21.4M added.
  • The largest Nektar Therapeutics seller in Q4 2015 was Millennium Management, an estimated $40.2M sold.

Based on aggregated 13F filings for Q4 2015.